Skip to content

HELX FRANKLIN TEMPLETON ETF TR

Follow

GENOMIC ADV ETF (fund)

10 managers (10 13F filers) reported a position in HELX shares at 2025-03-31, 81,687 shares in all. 2 filers opened a position and 2 filers sold out during the quarter.

Managers
10
13F filers
10
New
2
Added
5
Reduced
1
Sold out
2
Shares held by filers
81,687

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2025

Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC46,119$1.25M<0.01%+38,15313F-HRTimelineGroup
LPL Financial LLC17,850$482K<0.01%+88513F-HRTimeline
JANE STREET GROUP, LLCin group JANE STREET GROUP, LLC8,049$217K<0.01%-32,98113F-HR/ATimelineGroup
UBS Group AGin group UBS Group AG2,661$71.9K<0.01%+54413F-HRTimelineGroup
OSAIC HOLDINGS, INC.in group OSAIC HOLDINGS, INC.2,630$71K<0.01%new13F-HRTimelineGroup
HALBERT HARGROVE GLOBAL ADVISORS, LLC2,554$69K<0.01%+75313F-HRTimeline
HARBOUR INVESTMENTS, INC.1,823$49.2K<0.01%+1,68713F-HRTimeline
MORGAN STANLEYin group MORGAN STANLEY1$33<0.01%new13F-HRTimelineGroup
JPMORGAN CHASE & COin group JPMORGAN CHASE & CO0$1<0.01%013F-HRTimelineGroupAmount filed as zero, left out of ratios.
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$0013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.